Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000145

Director sold 1,458 shares at $21.73 ($31,682)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cook Jennifer E. Director 2024-06-06 Sale 10b5-1 −1,458 $21.73 $31,682 20,038 D
Open-market sales · 1,458 sh · avg $21.73 · $31,682
Loading xslF345X05/wk-form4_1718064363.xml…